Health Canada has issued a warning after discovering dangerous bacteria in tests conducted on over 11,000 vials of unauthorized peptides that were seized from online retailers. The substances in question were injectable peptides sourced from Shanghai ERP Peptide Biotechnology Co. Ltd., a Chinese-based wholesaler that was found to be supplying these products to two Canadian retailers, namely truenorthbiolabs.ca and bcaxiompeptide.com.
In the course of their tests, Health Canada examined more than 11,400 vials and identified the presence of bacteria capable of causing serious infections. Such findings raise alarming health concerns, especially considering the nature of these unauthorized peptides, which are often marketed for purposes like weight loss, muscle growth, anti-aging, and wellness enhancements.
Health Canada has emphasized that these unauthorized injectable peptides pose significant and unpredictable health risks to consumers. The agency stated, “Injecting contaminated products can cause serious infections, hospitalization, and in severe cases, life-threatening sepsis.” Additionally, the risk of developing infections is notably higher for individuals with compromised immune systems, making the use of such products extremely dangerous.
If individuals have used these unauthorized injectable peptide drugs and exhibit symptoms such as redness, swelling, or pain at the injection site, as well as fever, chills, or general malaise, Health Canada urges them to seek medical attention immediately. These symptoms could be indicative of a serious infection, thereby underscoring the need for prompt medical evaluation.
In light of these findings, Health Canada has taken enforcement action by shutting down the aforementioned websites responsible for selling these unauthorized peptides. Furthermore, the agency has mandated that ERP Peptide cease all illegal sales of these products into Canada. In addition to this, they have instructed the Canada Border Services Agency to prevent unauthorized shipments from entering the country, aiming to safeguard public health and ensure that consumers are not exposed to these harmful substances.
Consumers are advised to verify the legitimacy of any prescription drugs they consider using. Authorized medications in Canada will have an eight-digit Drug Identification Number (DIN) clearly labeled on the packaging. Health Canada provides a useful resource through its Drug Product Database, allowing individuals to check whether a specific drug has been officially authorized for sale in Canada. This can assist in preventing unintentional purchases of potentially harmful and unauthorized products.
